Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | J. Cortes | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | J. Ning | N. Pemmaraju | N. Jain | N. Short | P. Kebriaei | A. Maiti